 | • レポートコード：GIR201111140 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、フリードライヒ運動失調症治療薬の世界市場を調査対象にし、フリードライヒ運動失調症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ADVM-063、AGIL-FA、BHV-4157、BVA-202、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Adverum Biotechnologies Inc、Pfizer Inc、Cardero Therapeutics Inc、BioMarin Pharmaceutical Inc.、Ixchel Pharma LLC、Biovista Inc.、RaNA Therapeutics Inc、Forward Pharma A/S、Catabasis Pharmaceuticals, Inc.、ProQR Therapeutics NV、Voyager Therapeutics Inc、Reata Pharmaceuticals Inc、STATegics Inc、Retrotope Inc、Takeda ・メーカー別販売量、売上、市場シェア ・フリードライヒ運動失調症治療薬の地域別市場分析 ・フリードライヒ運動失調症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・フリードライヒ運動失調症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・フリードライヒ運動失調症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・フリードライヒ運動失調症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・フリードライヒ運動失調症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・フリードライヒ運動失調症治療薬の種類別市場規模2015-2020：ADVM-063、AGIL-FA、BHV-4157、BVA-202、その他 ・フリードライヒ運動失調症治療薬の用途別市場規模2015-2020：クリニック、病院、その他 ・フリードライヒ運動失調症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Friedreich Ataxia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Friedreich Ataxia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Friedreich Ataxia Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Friedreich Ataxia Drug market has been segmented into
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
By Application, Friedreich Ataxia Drug has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Friedreich Ataxia Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Friedreich Ataxia Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Friedreich Ataxia Drug market.
The report offers in-depth assessment of the growth and other aspects of the Friedreich Ataxia Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Friedreich Ataxia Drug Market Share Analysis
Friedreich Ataxia Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Friedreich Ataxia Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Friedreich Ataxia Drug sales, revenue and market share for each player covered in this report.
The major players covered in Friedreich Ataxia Drug are:
Adverum Biotechnologies Inc
Pfizer Inc
Cardero Therapeutics Inc
BioMarin Pharmaceutical Inc.
Ixchel Pharma LLC
Biovista Inc.
RaNA Therapeutics Inc
Forward Pharma A/S
Catabasis Pharmaceuticals, Inc.
ProQR Therapeutics NV
Voyager Therapeutics Inc
Reata Pharmaceuticals Inc
STATegics Inc
Retrotope Inc
Takeda
Among other players domestic and global, Friedreich Ataxia Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Friedreich Ataxia Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Friedreich Ataxia Drug, with price, sales, revenue and global market share of Friedreich Ataxia Drug in 2018 and 2019.
Chapter 3, the Friedreich Ataxia Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Friedreich Ataxia Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Friedreich Ataxia Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Friedreich Ataxia Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Friedreich Ataxia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Friedreich Ataxia Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ADVM-063
1.2.3 AGIL-FA
1.2.4 BHV-4157
1.2.5 BVA-202
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Friedreich Ataxia Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global Friedreich Ataxia Drug Market
1.4.1 Global Friedreich Ataxia Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Adverum Biotechnologies Inc
2.1.1 Adverum Biotechnologies Inc Details
2.1.2 Adverum Biotechnologies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Adverum Biotechnologies Inc SWOT Analysis
2.1.4 Adverum Biotechnologies Inc Product and Services
2.1.5 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cardero Therapeutics Inc
2.3.1 Cardero Therapeutics Inc Details
2.3.2 Cardero Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cardero Therapeutics Inc SWOT Analysis
2.3.4 Cardero Therapeutics Inc Product and Services
2.3.5 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioMarin Pharmaceutical Inc.
2.4.1 BioMarin Pharmaceutical Inc. Details
2.4.2 BioMarin Pharmaceutical Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioMarin Pharmaceutical Inc. SWOT Analysis
2.4.4 BioMarin Pharmaceutical Inc. Product and Services
2.4.5 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ixchel Pharma LLC
2.5.1 Ixchel Pharma LLC Details
2.5.2 Ixchel Pharma LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ixchel Pharma LLC SWOT Analysis
2.5.4 Ixchel Pharma LLC Product and Services
2.5.5 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biovista Inc.
2.6.1 Biovista Inc. Details
2.6.2 Biovista Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biovista Inc. SWOT Analysis
2.6.4 Biovista Inc. Product and Services
2.6.5 Biovista Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 RaNA Therapeutics Inc
2.7.1 RaNA Therapeutics Inc Details
2.7.2 RaNA Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 RaNA Therapeutics Inc SWOT Analysis
2.7.4 RaNA Therapeutics Inc Product and Services
2.7.5 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Forward Pharma A/S
2.8.1 Forward Pharma A/S Details
2.8.2 Forward Pharma A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Forward Pharma A/S SWOT Analysis
2.8.4 Forward Pharma A/S Product and Services
2.8.5 Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Catabasis Pharmaceuticals, Inc.
2.9.1 Catabasis Pharmaceuticals, Inc. Details
2.9.2 Catabasis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Catabasis Pharmaceuticals, Inc. SWOT Analysis
2.9.4 Catabasis Pharmaceuticals, Inc. Product and Services
2.9.5 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ProQR Therapeutics NV
2.10.1 ProQR Therapeutics NV Details
2.10.2 ProQR Therapeutics NV Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ProQR Therapeutics NV SWOT Analysis
2.10.4 ProQR Therapeutics NV Product and Services
2.10.5 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Voyager Therapeutics Inc
2.11.1 Voyager Therapeutics Inc Details
2.11.2 Voyager Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Voyager Therapeutics Inc SWOT Analysis
2.11.4 Voyager Therapeutics Inc Product and Services
2.11.5 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Reata Pharmaceuticals Inc
2.12.1 Reata Pharmaceuticals Inc Details
2.12.2 Reata Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Reata Pharmaceuticals Inc SWOT Analysis
2.12.4 Reata Pharmaceuticals Inc Product and Services
2.12.5 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 STATegics Inc
2.13.1 STATegics Inc Details
2.13.2 STATegics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 STATegics Inc SWOT Analysis
2.13.4 STATegics Inc Product and Services
2.13.5 STATegics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Retrotope Inc
2.14.1 Retrotope Inc Details
2.14.2 Retrotope Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Retrotope Inc SWOT Analysis
2.14.4 Retrotope Inc Product and Services
2.14.5 Retrotope Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Takeda SWOT Analysis
2.15.4 Takeda Product and Services
2.15.5 Takeda Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Friedreich Ataxia Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Friedreich Ataxia Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Friedreich Ataxia Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Friedreich Ataxia Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Friedreich Ataxia Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Friedreich Ataxia Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Friedreich Ataxia Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
4.3 Europe Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
4.5 South America Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Friedreich Ataxia Drug Sales, Revenue and Market Share by Country
5.1.1 North America Friedreich Ataxia Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Friedreich Ataxia Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
5.3 Canada Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Friedreich Ataxia Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Friedreich Ataxia Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Friedreich Ataxia Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
6.3 UK Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
6.4 France Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
6.5 Russia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
6.6 Italy Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Friedreich Ataxia Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Friedreich Ataxia Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Friedreich Ataxia Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7.3 Japan Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7.4 Korea Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7.5 India Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
7.7 Australia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Friedreich Ataxia Drug Sales, Revenue and Market Share by Country
8.1.1 South America Friedreich Ataxia Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Friedreich Ataxia Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Friedreich Ataxia Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Friedreich Ataxia Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Friedreich Ataxia Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Friedreich Ataxia Drug Sales and Market Share by Type (2015-2020)
10.2 Global Friedreich Ataxia Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Friedreich Ataxia Drug Price by Type (2015-2020)
11 Global Friedreich Ataxia Drug Market Segment by Application
11.1 Global Friedreich Ataxia Drug Sales Market Share by Application (2015-2020)
11.2 Global Friedreich Ataxia Drug Revenue Market Share by Application (2015-2020)
11.3 Global Friedreich Ataxia Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Friedreich Ataxia Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Friedreich Ataxia Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Friedreich Ataxia Drug Market Forecast (2021-2025)
12.2.2 Europe Friedreich Ataxia Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Friedreich Ataxia Drug Market Forecast (2021-2025)
12.2.4 South America Friedreich Ataxia Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Friedreich Ataxia Drug Market Forecast (2021-2025)
12.3 Friedreich Ataxia Drug Market Forecast by Type (2021-2025)
12.3.1 Global Friedreich Ataxia Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Friedreich Ataxia Drug Market Share Forecast by Type (2021-2025)
12.4 Friedreich Ataxia Drug Market Forecast by Application (2021-2025)
12.4.1 Global Friedreich Ataxia Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Friedreich Ataxia Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Friedreich Ataxia Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Friedreich Ataxia Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Friedreich Ataxia Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Adverum Biotechnologies Inc Basic Information, Manufacturing Base and Competitors
Table 8. Adverum Biotechnologies Inc Friedreich Ataxia Drug Major Business
Table 9. Adverum Biotechnologies Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 10. Adverum Biotechnologies Inc SWOT Analysis
Table 11. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product and Services
Table 12. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc Friedreich Ataxia Drug Major Business
Table 15. Pfizer Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer Inc SWOT Analysis
Table 17. Pfizer Inc Friedreich Ataxia Drug Product and Services
Table 18. Pfizer Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cardero Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 20. Cardero Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 21. Cardero Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 22. Cardero Therapeutics Inc SWOT Analysis
Table 23. Cardero Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 24. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BioMarin Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 26. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Major Business
Table 27. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 28. BioMarin Pharmaceutical Inc. SWOT Analysis
Table 29. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product and Services
Table 30. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ixchel Pharma LLC Basic Information, Manufacturing Base and Competitors
Table 32. Ixchel Pharma LLC Friedreich Ataxia Drug Major Business
Table 33. Ixchel Pharma LLC Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 34. Ixchel Pharma LLC SWOT Analysis
Table 35. Ixchel Pharma LLC Friedreich Ataxia Drug Product and Services
Table 36. Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biovista Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Biovista Inc. Friedreich Ataxia Drug Major Business
Table 39. Biovista Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 40. Biovista Inc. SWOT Analysis
Table 41. Biovista Inc. Friedreich Ataxia Drug Product and Services
Table 42. Biovista Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. RaNA Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. RaNA Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 45. RaNA Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 46. RaNA Therapeutics Inc SWOT Analysis
Table 47. RaNA Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 48. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Forward Pharma A/S Basic Information, Manufacturing Base and Competitors
Table 50. Forward Pharma A/S Friedreich Ataxia Drug Major Business
Table 51. Forward Pharma A/S Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 52. Forward Pharma A/S SWOT Analysis
Table 53. Forward Pharma A/S Friedreich Ataxia Drug Product and Services
Table 54. Forward Pharma A/S Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Catabasis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Major Business
Table 57. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 58. Catabasis Pharmaceuticals, Inc. SWOT Analysis
Table 59. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product and Services
Table 60. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. ProQR Therapeutics NV Basic Information, Manufacturing Base and Competitors
Table 62. ProQR Therapeutics NV Friedreich Ataxia Drug Major Business
Table 63. ProQR Therapeutics NV Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 64. ProQR Therapeutics NV SWOT Analysis
Table 65. ProQR Therapeutics NV Friedreich Ataxia Drug Product and Services
Table 66. ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Voyager Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 68. Voyager Therapeutics Inc Friedreich Ataxia Drug Major Business
Table 69. Voyager Therapeutics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 70. Voyager Therapeutics Inc SWOT Analysis
Table 71. Voyager Therapeutics Inc Friedreich Ataxia Drug Product and Services
Table 72. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Reata Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Major Business
Table 75. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 76. Reata Pharmaceuticals Inc SWOT Analysis
Table 77. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product and Services
Table 78. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. STATegics Inc Basic Information, Manufacturing Base and Competitors
Table 80. STATegics Inc Friedreich Ataxia Drug Major Business
Table 81. STATegics Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 82. STATegics Inc SWOT Analysis
Table 83. STATegics Inc Friedreich Ataxia Drug Product and Services
Table 84. STATegics Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Retrotope Inc Basic Information, Manufacturing Base and Competitors
Table 86. Retrotope Inc Friedreich Ataxia Drug Major Business
Table 87. Retrotope Inc Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 88. Retrotope Inc SWOT Analysis
Table 89. Retrotope Inc Friedreich Ataxia Drug Product and Services
Table 90. Retrotope Inc Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Takeda Basic Information, Manufacturing Base and Competitors
Table 92. Takeda Friedreich Ataxia Drug Major Business
Table 93. Takeda Friedreich Ataxia Drug Total Revenue (USD Million) (2018-2019)
Table 94. Takeda SWOT Analysis
Table 95. Takeda Friedreich Ataxia Drug Product and Services
Table 96. Takeda Friedreich Ataxia Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Friedreich Ataxia Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Friedreich Ataxia Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Friedreich Ataxia Drug Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Friedreich Ataxia Drug Sales Market Share by Regions (2015-2020)
Table 101. Global Friedreich Ataxia Drug Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 104. North America Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 106. Europe Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 108. Europe Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Friedreich Ataxia Drug Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Friedreich Ataxia Drug Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 114. South America Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Friedreich Ataxia Drug Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Friedreich Ataxia Drug Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Table 120. Global Friedreich Ataxia Drug Sales by Type (2015-2020) (K Pcs)
Table 121. Global Friedreich Ataxia Drug Sales Share by Type (2015-2020)
Table 122. Global Friedreich Ataxia Drug Revenue by Type (2015-2020) (USD Million)
Table 123. Global Friedreich Ataxia Drug Revenue Share by Type (2015-2020)
Table 124. Global Friedreich Ataxia Drug Sales by Application (2015-2020) (K Pcs)
Table 125. Global Friedreich Ataxia Drug Sales Share by Application (2015-2020)
Table 126. Global Friedreich Ataxia Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Friedreich Ataxia Drug Market Share Forecast by Regions (2021-2025)
Table 128. Global Friedreich Ataxia Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Friedreich Ataxia Drug Market Share Forecast by Type (2021-2025)
Table 130. Global Friedreich Ataxia Drug Sales Forecast by Application (2021-2025)
Table 131. Global Friedreich Ataxia Drug Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Friedreich Ataxia Drug Picture
Figure 2. Global Sales Market Share of Friedreich Ataxia Drug by Type in 2019
Figure 3. ADVM-063 Picture
Figure 4. AGIL-FA Picture
Figure 5. BHV-4157 Picture
Figure 6. BVA-202 Picture
Figure 7. Others Picture
Figure 8. Friedreich Ataxia Drug Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Friedreich Ataxia Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Friedreich Ataxia Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Friedreich Ataxia Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Friedreich Ataxia Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Friedreich Ataxia Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Friedreich Ataxia Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Friedreich Ataxia Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Friedreich Ataxia Drug Revenue Market Share by Regions in 2018
Figure 41. North America Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Friedreich Ataxia Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Friedreich Ataxia Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Friedreich Ataxia Drug Sales Market Share by Countries in 2018
Figure 49. North America Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Friedreich Ataxia Drug Revenue Market Share by Countries in 2018
Figure 51. United States Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Friedreich Ataxia Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Friedreich Ataxia Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Friedreich Ataxia Drug Revenue Market Share by Regions 2019
Figure 65. China Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Friedreich Ataxia Drug Sales Market Share by Countries in 2019
Figure 72. South America Friedreich Ataxia Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Friedreich Ataxia Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Friedreich Ataxia Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Friedreich Ataxia Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Friedreich Ataxia Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Friedreich Ataxia Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Friedreich Ataxia Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Friedreich Ataxia Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Friedreich Ataxia Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Friedreich Ataxia Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Friedreich Ataxia Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Friedreich Ataxia Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
甲状腺機能低下症治療の世界市場 2020年 Market Overview The global Hypothyroidism Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hypothyroidism Drug marke…- 小売用医薬品の世界市場 2020年 Market Overview The global Retail Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1350.1 million by 2025, from USD 1211 million in 2019. The Retail Drug market report …
- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…
- アンカ血管炎薬の世界市場 2020年 Market Overview The global Anca Vasculitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anca Vasculitis Drug mar…
- アンブリセンタン薬の世界市場 2020年 Market Overview The global Ambrisentan Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ambrisentan Drug market repo…